Displaying drugs 12526 - 12550 of 12628 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| NCX 950 | Not Available |  | Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD). | Not Available |
| Trichloroacetate | Not Annotated |  | Trichloroacetate, or trichloroacetic acid, is a strong acid prepared by the reaction of chlorine with acetic acid in the presence of a suitable catalyst. In clinical chemistry and biochemistry, it... | Caustics / Chloroacetates / Trichloroacetic Acid |
| Pristinamycin | Not Annotated |  | Not Annotated | Streptogramins |
| Nolpitantium chloride | Not Annotated |  | Not Annotated | Not Annotated |
| SNSP113 | Not Annotated |  | Not Annotated | Not Annotated |
| Lanolin alcohols | Not Annotated |  | Lanolin alcohols are a complex combination of organic alcohols obtained by the hydrolysis of lanolin. It is administered as an ointment base with topical insulin and has shown to be... | Standardized Chemical Allergen |
| Biomed 101 | Not Available |  | Investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. | Not Available |
| Amylose | Not Annotated |  | Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial). | Starch |
| TM30339 | Not Available |  | Investigated for use/treatment in schizophrenia and schizoaffective disorders. | Not Available |
| Butylidenephthalide | Not Annotated |  | Not Annotated | Acids, Carbocyclic / Anhydrides / Phthalic Acids |
| YKP-1358 | Not Annotated |  | Investigated for use/treatment in schizophrenia and schizoaffective disorders. | Dopamine D2 Receptor Antagonists / Serotonin 5-HT2 Receptor Antagonists |
| CLX-0921 | Not Available |  | Investigated for use/treatment in diabetes mellitus type 2. | Sulfur Compounds |
| Birch bark extract | Not Available |  | A herbal medicinal product used to treat partial thickness wounds. | Anti-Inflammatory Agents / Anti-inflammatory Agents, Miscellaneous / Biological Products / Complex Mixtures / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Plant Preparations / Triterpenes / Wound Healing |
| CP-96345 | Not Annotated |  | Not Annotated | Anti-Inflammatory Agents, Non-Steroidal / Hypnotics and Sedatives / Substance P, antagonists & inhibitors |
| Excindogen | Not Annotated |  | Excindogen is an investigational immunotherapy. | Not Annotated |
| AB192 | Not Annotated |  | Investigated for use/treatment in diabetes mellitus type 2. | Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors |
| CPD 923 | Not Available |  | Investigated for use/treatment in metabolic disease. | Not Available |
| Omburtamab I-131 | Not Annotated |  | Not Annotated | Iodine (131I) Compounds |
| IKT-001Pro | Not Annotated |  | Not Annotated | Kinase Inhibitor |
| Neomycin | Not Available |  | An aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body. | Antiinfectives and Antiseptics for Local Oral Treatment |
| FP0011 | Not Available |  | Investigated for use/treatment in amyotrophic lateral sclerosis (ALS) and parkinson's disease. | Not Available |
| SO-101 | Not Available |  | Investigated for use/treatment in insomnia. | Not Available |
| M0002 | Not Available |  | Vasopressin regulates renal water resorption through the V2 receptor. Inhibition of vasopressin’s effects on V2 receptors enhances water excretion and increases urinary output. M0002 is a Vasopressin 2 antagonis. It... | Not Available |
| WL-1002 | Not Available |  | Investigated for use/treatment in osteoarthritis and pain (acute or chronic). | Not Available |
| Technetium Tc-99m exametazime | Not Available |  | A radiopharmaceutical diagnostic agent used as an adjunct for scintigraphy in the detection of altered regional cerebral perfusion in stroke. | Technetium (99Mtc) Compounds |
Displaying drugs 12526 - 12550 of 12628 in total